| Date | Source | Title | Awardee | Value |
|---|---|---|---|---|
| 2026-10-01 | sam | 6505--Fluorodeoxyglucose (FDG) Radiopharmaceutical | CARDINAL HEALTH 414, LLC | $638K |
| 2026-10-01 | sam | 6505--Lab Supplies | Radiopharm | New 5 year consolidation L | CARDINAL HEALTH 414, LLC | $4.6M |
| 2026-10-01 | sam | 6505--Fluorodeoxyglucose (FDG) Radiopharmaceutical | CARDINAL HEALTH 414, LLC | $638K |
| 2026-09-17 | sam | 6505--Vivus LLC, 65IB, 36F79726D0185, Performance Period: 0 | VIVUS LLC | $285.7M |
| 2026-09-14 | sam | Bausch Health US, LLC Award 09/30/2026 - 09/30/2031 | BAUSCH HEALTH US LLC | $3.68B |
Get the complete 22-award history, momentum signals, stock metrics, institutional holdings, and real-time alerts.
Subscribe — $19.95 / month